Invesco NASDAQ Biotechnology ETF
IBBQ
17 hedge funds and large institutions have $10.9M invested in Invesco NASDAQ Biotechnology ETF in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
42% more funds holding
Funds holding: 12 → 17 (+5)
36% more capital invested
Capital invested by funds: $8.05M → $10.9M (+$2.86M)
3.85% less ownership
Funds ownership: 40.87% → 37.02% (-3.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EA
Eudaimonia Advisors
Winchester,
Tennessee
|
+$1.57M |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$1.03M |
| 3 |
EP
Eudaimonia Partners
Winchester,
Tennessee
|
+$922K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$83.1K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$73.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$507K |
| 2 |
PCIG
Partners Capital Investment Group
Boston,
Massachusetts
|
-$286K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$206K |
| 4 |
TWM
Tradition Wealth Management
Edina,
Minnesota
|
-$13K |
IBBQ Hedge Fund Activity: Q1 2024 in Review
17 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q1 2024, worth a combined $10.9M — up 36% from $8.05M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new IBBQ positions and 1 closed out — a net gain of 5 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Eudaimonia Advisors, opening a new position worth an estimated $1.57M. The largest seller was Bank of America, cutting an estimated $507K.
- 17 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q1 2024, up from 12 in Q4 2023.
- Funds reported $10.9M of Invesco NASDAQ Biotechnology ETF stock for Q1 2024, up 36% quarter-over-quarter.
- 6 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q1 2024 and 1 closed out, a net change of +5 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q1 2024 was Eudaimonia Advisors, an estimated $1.57M added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q1 2024 was Bank of America, an estimated $507K sold.
Based on aggregated 13F filings for Q1 2024.